Assess the Safety and Activity of Combined MG005 and Sorafenib (NEXAVAR®) Treatment With Solid Tumor
Clinical trial NCT03406364 · COMPLETED
Trial details
- NCT number
- NCT03406364
- Sponsor
- Metagone Biotech Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-06-06
- Primary completion
- 2020-01-09
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.